Tag Archives: stocks

IPO Stock Watch: Global Blood Doubles On First Day

Global Blood Therapeutics (GBT) shrugged off the recent slump in biotech stocks and screamed up 130% as of late afternoon on its first day of trading Wednesday, after pricing its 6-million-share IPO at 20, above the expected range. The initial public offering raised $120 million. Global Blood is developing treatments for blood disorders, particularly sickle-cell disease (SCD), a genetic condition that causes anemia. Its lead candidate entered

3 Key Biotech Drug Approvals Expected This Month

The second half of August is usually a desert for business news, but the FDA schedule is year-round. Several important drugs are up for approval decisions this month, which could provide some upside for three biotech stocks that have recently been suffering. Getting the most attention will likely be Repatha, Amgen’s (AMGN) cholesterol drug. It’s expected to be approved by Aug. 27. Repatha is a PCSK9 inhibitor similar to Praluent, the drug from